Revenue

Record overseas buyer attendance at the 139th Canton Fair highlights a strategic pivot to high-tech, innovative manufacturing, reshaping global trade.

TCI's Q1 net income fell to just $0.2M from $4.6M a year ago, hit by rising costs and the absence of a major one-time gain from 2025.

Barings BDC maintained its dividend, but a dip in income and net asset value reveals underlying challenges in a volatile market for private credit.

The gas and convenience retailer's massive dividend hike follows a stellar quarter, showcasing financial strength in a shifting market.

Facing financial pressures, the biotech divests a key cancer program, repays debt, and now explores all options to maximize value for its remaining pipeline.

The online therapy giant launches a massive giveback, partnering with the WNBA and nonprofits to address the silent mental health crisis facing mothers.

The service commerce platform saw net income jump over 700% despite a drop in adjusted EBITDA, signaling a massive strategic bet on its AI-driven future.

Amidst a 20% workforce cut, Geospace Technologies reports wider losses, testing its high-stakes strategy to pivot from oil & gas to new tech markets.

The media giant posted strong Q3 results, driven by a bold strategy to monetize its content with AI partners while aggressively suing content scrapers.

The environmental services firm posted sequential growth and cut costs, signaling a strategic pivot despite a year-over-year revenue dip.

The institutional crypto exchange is filing for CFTC licenses, a move that could unlock institutional capital and reshape the US digital asset market.

Amid declining Q1 income and NAV, the lender bets on a major healthcare acquisition and a new buyback to bolster shareholder confidence and future growth.

As complex new global AI and data laws take effect, Canadian businesses are scrambling for guidance, fueling a boom in specialized advisory services.

Despite a Q1 net loss, Mach Natural Resources boosts its cash distribution and shifts capital to oil, signaling confidence in its operational strength.

The cloud company's results show modest growth, but a strategic pivot to shed a recent acquisition and focus on its 'Dash' AI tool is paying off.

The AI data protection leader smashed Q1 estimates, raising its full-year outlook as demand for AI governance solutions fuels record revenue and profitability.

The biotech supplier swung to profitability and positive cash flow, driven by a major cost overhaul and strong demand in its core nucleic acid business.

The LGBTQ+ app reports record Q1 earnings and plans a premium 'Edge' service, but faces growing challenges with data privacy and anti-gay policies.

The chipmaker topped Q1 estimates and eyes a strong Q2, fueled by EV and AI markets, even as restructuring charges weigh on its bottom line.

With a strong balance sheet and promising data, Enliven Therapeutics is pushing its lead leukemia drug, ELVN-001, into a pivotal late-stage trial.